首页 正文

Hypertension associated with systemic therapy for hepatocellular carcinoma and management strategies

{{output}}
Antiangiogenic therapy and immune checkpoint inhibitors represent two cornerstone approaches in the current systemic treatment of patients with hepatocellular carcinoma (HCC). Since the advent of the immunotherapy era, the survival of patients with HCC, partic... ...